INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🟢 Indaptus Therapeutics is trading 14% up today after sharply narrower losses and strategic shift
Indaptus Therapeutics is trading 14.02% up at $1.22 after its August 13, 2026 second-quarter report highlighted sharply narrower losses and a strategic shift...
🟢 Indaptus Therapeutics is trading 7% up today
Indaptus Therapeutics is trading 7.01% up now at $1.15, extending its recent rebound after closing at $1.07 on August 14, 2026. - No new company-specific...
Indaptus Shares Jump 8.5% on Narrower Losses, but With No Drug in the Clinic, What Exactly Are Investors Buying?
Shares of Indaptus Therapeutics shifted sharply higher on Aug. 14, rising 8.5% to $1.15, after the micro-cap biotech reported second-quarter results that beat...
🟢 Indaptus Therapeutics is trading 8.5% up today after Q2 results reportedly beat estimates
Indaptus Therapeutics is trading 8.5% up now at $1.15 after its August 13, 2026, second-quarter results reportedly beat estimates, with a narrowed $1.8 million...
🟢 Indaptus Therapeutics is trading 5.66% up in pre-market after net loss narrows to $1.8 million
Indaptus Therapeutics is trading 5.66% up in pre-market at $1.12 after August 13, 2026, second-quarter results showed net loss narrowing to approximately $1.8...
🟢 Indaptus Therapeutics is trading 5.65% up in after-hours trading after reporting a narrower second-quarter loss
Indaptus Therapeutics is trading 5.65% up at $1.12 in after-hours trading after its August 13, 2026, second-quarter earnings release and narrower loss. - Net...
🟢 Indaptus Therapeutics is trading 5% up today after narrower second-quarter loss
Indaptus Therapeutics is trading 5.32% up now at $1.08 after reporting second-quarter 2026 results on August 13, 2026. - Net loss narrowed to $1.8 million...
🟢 Indaptus Therapeutics is trading 6% up in pre-market after narrower second-quarter loss
Indaptus Therapeutics is trading at $1.09 (+5.83%) now after releasing second-quarter 2026 results on August 13, 2026, which showed net loss narrowed to...
Indaptus Therapeutics second quarter 2026 net loss narrows to $1.8M amid clinical trial halt
Indaptus reported a significant reduction in operating expenses for the second quarter of 2026 as the company effectively halted its active clinical...
🔴 Indaptus Therapeutics is trading 10.08% down today with no confirmed company-specific announcement
Indaptus Therapeutics is trading 10.08% down at $1.07, with no confirmed company-specific announcement identified for August 12, 2026. - Search results show...
🔴 Indaptus Therapeutics is trading 5.46% down today — no confirmed company-specific catalyst
Indaptus Therapeutics is trading 5.46% down at $1.12 based on the provided live price context; searches found no confirmed company-specific announcement on...
🟢 Indaptus Therapeutics is trading 5.89% up today with no confirmed company-specific catalyst
Indaptus Therapeutics is trading $1.26, up +5.89%, with no confirmed company-specific announcement explaining the August 11, 2026 gain. - Investors may be...
Indaptus Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Analysts expect Indaptus Therapeutics to report a consensus EPS loss of -$0.36 for Q2 2026 on zero revenue, with the stock currently trading at $1.56 against...
🟢 Indaptus Therapeutics is trading 5.81% up in pre-market with no clear catalyst identified
Indaptus Therapeutics is trading 5.81% up at $1.25 after no clear company-specific catalyst was identified for August 10, 2026. - Its virtual annual meeting...
🔴 Indaptus Therapeutics is trading 10.24% down today — no clear company-specific catalyst
Indaptus Therapeutics is trading 10.24% down now at $1.19 after searches found no clear company-specific announcement explaining the August 6, 2026 decline. -...
🔴 Indaptus Therapeutics is trading 9.78% down today — no clear company-specific catalyst
Indaptus Therapeutics is trading 9.78% down now at $1.20 after no clear company-specific catalyst emerged in the August 6, 2026 news search. - Recent coverage...
🟢 Indaptus Therapeutics is trading 14.29% up today on speculative trading with no clear catalyst
Indaptus Therapeutics is trading at $1.52 (+14.29%) in pre-market sessions despite a lack of identifiable company-specific catalysts in current news flow. *...
🟢 Indaptus Therapeutics is trading 5.3% up today on technical buying and risk-on sentiment
Indaptus Therapeutics is trading 5.3% up at $1.38 as the stock stages a technical rebound following a sharp multi-day selloff. • The recovery follows a period...
🔴 Indaptus Therapeutics is trading 7.6% down today reversing an earlier technical rebound
Indaptus Therapeutics is trading at $1.21 (7.6% down) in after-hours trading, reversing part of a sharp intraday rebound. • The stock climbed approximately...
🟢 Indaptus Therapeutics is trading 10.1% up today on a technical rebound after a sharp multi-day selloff
Indaptus Therapeutics is trading 10.1% up at $1.42 in what appears to be a technical rebound after a sharp multi-day selloff. • There are no fresh...